MEDIRISM

Medirism Co., Ltd. · Tokyo

Toward the leading
AI company in pharma

We help pharmaceutical marketers perform at their best, with AI built for pharma marketing and hands-on consulting.

Much of a pharma marketer's time goes into gathering information, building documents and countless administrative tasks. With AI that understands the pharma context, and support from people who have done the job themselves, we create an environment where marketers can focus on their real work: thinking, deciding, and working with and leading other functions.

AI Product · Skanda

End-to-end AI support for pharma marketing work

Named after Skanda (Idaten), the swift guardian of order.

Overwhelming speed and reliable safeguards, together, for pharma marketing.

The central mission of pharma marketing is to deliver the right information to patients and healthcare professionals as quickly as possible, while working from a vast body of scientific evidence and complying with strict rules. Yet the more carefully teams proceed, the more fragmented the process becomes, and speed is lost.

The name Skanda comes from the symbol of swiftness who races freely in every direction (Idaten), and the guardian deity who has long protected order.

On a solid foundation of strict compliance and information security, we built Skanda as an AI agent specialised in pharma marketing that runs straight through from strategy planning to execution support. It is a partner for marketers: supporting complex work at speed and unlocking the potential of the team.

What sets it apart

  • External × internal. Insight you can use today comes from combining the latest industry information with your own latest internal documents. Skanda draws on both and cites its sources.
  • People ensure input quality. The quality of an AI's answers depends on what goes in. Medirism's pharma marketing practitioners help select sources and organise internal data, so it is not "garbage in, garbage out".
  • Covers most of the marketing workflow. Information gathering, analysis and market research, strategy documents and promotional materials, handled by specialised agents on one shared platform.

Your internal data is kept in a separate environment for each company and is never used to train models for, or shared with, other customers. We prepare documentation for global IT and vendor security reviews as part of PoC design.

Consulting

Not just drawing up the strategy, but working as part of your team

Practitioners with hands-on pharma marketing experience support you from launch strategy to market research, materials and promotion.

  • Launch excellence: brand planning, KSF and cross-SWOT, KOL engagement, launch readiness
  • Commercial strategy for rare and intractable diseases
  • Market research design and analysis
  • Materials and promotion strategy

We work inside your team

Rather than handing over a report and leaving, we join your marketing team's regular and project meetings, build the materials, and help drive internal alignment.

We move fast, with AI as standard

We use security-assured AI for information gathering, analysis and document creation, so even a small team delivers with the speed and quality of a large consulting firm.

Track record with more than ten pharmaceutical companies in Japan and abroad. Client names and project details are not disclosed for confidentiality reasons.

Media · What to Noh

Media that people in the pharma industry can use in their work

What to Noh publishes primary news from the pharma industry every day: new data, approvals, drug pricing, regulation and corporate results. Beyond the information itself, we publish analysis to help readers think through what each piece of news means for people working at pharmaceutical companies.

Public information such as Ministry of Health, Labour and Welfare releases, corporate results and drug pricing is also structured so that it can be used as a database.

We welcome enquiries about partnerships around media and data, as well as requests for interviews, articles and talks on pharma marketing, commercial strategy for rare diseases and AI in the pharma industry.

Why Medirism

Product design grounded in deep industry domain knowledge

Pharma marketing calls for deep knowledge specific to this field and an understanding of the industry's rules: the latest literature, healthcare policy trends, market research results and secondary data. Tools built without that understanding do not get used in the field. Both Skanda and our consulting are designed from real experience working in pharma marketing at pharmaceutical companies.

  1. 01

    Expertise

    Designed on the basis of hands-on experience in pharma marketing. We also put that experience to work in our consulting.

    Deep practical experience
  2. 02

    Support for pharmaceutical companies

    From the Japanese affiliates of global pharmaceutical companies to mid-sized domestic companies, we support pharma marketing with a focus on launch strategy and product strategy.

    10+companies
  3. 03

    Skanda early adoption

    A PoC is under way with a major pharmaceutical company. We are accepting partners for a paid early-adoption programme that focuses on specific products and therapeutic areas and tests the impact in real work.

    PoC under way

CEO Message

Taro Watanabe, Representative Director & CEO

Representative Director & CEO

Taro Watanabe

Because we know the field of pharma marketing, we can build AI that actually works.

Starting from my experience as a medical representative at Takeda Pharmaceutical, I led launch projects for rare-disease and regenerative-medicine products in business planning and marketing, and went on to serve at Janssen Pharmaceutical (J&J) as head of rare-disease marketing in Japan and lead for rare-disease pipeline products across Asia-Pacific.

What I saw first-hand was that much of a marketer's time goes into administrative work centred on gathering information and building documents, while the work that deserves the most time, thinking through strategy and making decisions, keeps getting pushed back.

Generative AI has driven major gains in efficiency, but how people use it varies widely, and my impression is that it is actually widening the gap in individual performance. To build AI agents that genuinely work inside business processes, they have to be built by people who know the work well. That is why we are developing Skanda, an AI specialised in pharma marketing.

At the same time, through consulting we contribute directly to the work of pharmaceutical companies, and we feed the issues and insights we gain there back into the AI to raise its quality. Through this cycle, we aim to become the leading AI company in pharma.

We would welcome the chance to hear about your pharma marketing challenges.

Company
Medirism Co., Ltd. (株式会社メディリズム)
Address
N&E BLD. 6F, 1-12-4 Ginza, Chuo-ku, Tokyo 104-0061, Japan
Founded
February 2024
CEO
Taro Watanabe
Business
Development and provision of Skanda, an AI specialised in pharma marketing
Consulting for pharmaceutical companies
Operation of What to Noh, a media outlet for the pharma industry

Careers

Shaping a new chapter for the pharma industry, together

We are looking for people who want to build the leading AI company in pharma with us.

Contact

Tell us about your
pharma marketing challenges

For Skanda PoC enquiries, consulting, partnerships, press or careers, please email us or use our contact form.

contact@medirism.com